Latest news
Eris Lifesciences draws ₹64.40 Cr working capital term loan from Axis Bank - scanx.tradescanx.trade · Thu, 06 Aug 2026 04:17:52 GMTHere's What Analysts Are Forecasting For Eris Lifesciences Limited (NSE:ERIS) After Its First-Quarter Results - webull.comwebull.com · Tue, 04 Aug 2026 13:47:46 GMTEris Lifesciences Q1 Results: Earnings Call Transcript Released for Review - scanx.tradescanx.trade · Tue, 04 Aug 2026 05:26:45 GMTBajaj Housing Finance, Radico, Equitas SFB, KPIT Tech, Eris, Vinati Organics And More Q1 Review — Check Motilal Oswal's Latest Ratings, Target Prices, Upside Potential - NDTV ProfitNDTV Profit · Thu, 30 Jul 2026 07:00:00 GMTEris Lifesciences to host virtual analyst meet with Bandhan Mutual Fund on Aug 4 - scanx.tradescanx.trade · Thu, 30 Jul 2026 07:00:00 GMTEris Life to add insulin aspart this calendar; sees semaglutide uptake improving on weight-loss tag - ET PharmaET Pharma · Wed, 29 Jul 2026 17:25:25 GMTEris Lifesciences posts 13% revenue growth in Q1 FY27; PAT rises 14.5% - Indian Pharma PostIndian Pharma Post · Wed, 29 Jul 2026 14:33:36 GMTEris Lifesciences Q1 PAT rises 14.5% on strong domestic formulations growth; insulin, GLP-1 businesses shine - TradingViewTradingView · Wed, 29 Jul 2026 11:15:52 GMT